LGALS13 and preeclampsia: This is in line with the data from the PROGNOSIS study where the authors decribed a cut-off value of 38 for the sFLT1/PGF ratio.[29] Interestingly, the data on LGALS13 did not show an increase in cases with preeclampsia, different to what has been described before.[8,30]